Stockreport

Agile Therapeutics Announces FDA Advisory Committee Meeting for its Investigational Transdermal Low-Dose Contraceptive Patch, Twirla® (AG200-15)

Agile Therapeutics, Inc.  (AGRX) 
Last agile therapeutics, inc. earnings: 5/2 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.agiletherapeutics.com/investor-relations
PDF Meeting Scheduled for October 30, 2019 FDA Previously Assigned PDUFA (Prescription Drug User Fee Act) Goal Date is November 16, 2019 PRINCETON, N.J., June 24, 201 [Read more]